1111164

Martin Neil Reaume, MD — FEI 3015602595

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 15, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ottawa (Canada)

Additional Details

Clinical Investigator (CI)